Coumarin-modified ruthenium complexes by disrupting bacterial membrane to combat Gram-positive bacterial infection

Huang Hai-Yan,Wang Pei,Wei Deng,Li-Xin Dou,Xiangwen Liao,Jintao Wang,Xuemin Duan,Yu Rujian,Yan-Shi Xiong

DOI: https://doi.org/10.1039/d3dt01287e

IF: 4

2023-06-20

Dalton Transactions

Abstract:Antibiotics abuse has caused the generation of drug-resistant bacteria and a series of infections induced by multidrug-resistant bacteria have become a threat to human health. Facing the failure of traditional antibiotics, antibacterial drugs with new molecular and action modes were urgently need to developed. In this study, ruthenium complexes containing coumarin were designed and synthesized. By altering the structure of ancillary ligand, we explored the biological activities of four ruthenium complexes against Staphylococcus aureus. Among them, Ru(II)-1 with the best antibacterial activity (Minimum inhibitory concentration: 1.56 μg/mL),which was used to further investigate. Surprisingly, Ru(II)-1 could significantly inhibit the formation of biofilm and uneasily development of bacteria drug-resistant. Besides, Ru(II)-1 also exhibited excellent biocompatibility. Antibacterial mechanism studies suggested that Ru(II)-1 could target to the bacterial cell membrane and combine with the phospholipid component of membrane (phosphatidylglycerol and phosphatidylethanolamine), and generate reactive oxygen species to induce oxidative stress response, which resulted in the damage of membrane integrity and finally leading bacteria death. Moreover, antibacterial tests in G. mellonella larvae and mice in vivo model indicated that Ru(II)-1 had a potential to combat S. aureus infection. Therefore, all the above results showed that ruthenium complexes modified with coumarin could be a promising antibacterial agent to tackle bacterial infection problem.

chemistry, inorganic & nuclear